Christophe co-founded Genomatica and has served as our Chief Executive Officer since May 2009. Christophe holds a Ph.D. in bioengineering from the University of California, San Diego where he was a Powell Foundation and Whitaker Foundation Fellow. He received a B.S. in biomedical engineering from Duke University where he was a Howard Hughes Undergraduate Research Fellow. Christophe’s awards include the Top 100 Young Innovators from MIT’s Technology Review, R&D100 for the SimPheny part of the company’s technology platform, and the Distinguished Young Alumnus from Duke University’s Edmund T. Pratt, Jr. School of Engineering.

Mike has served as our Executive Vice President and Chief Financial Officer since July 2011. From September 2008 to July 2011, Mike served in various roles at Clipper Windpower, Inc., a wind energy technology company, including Senior Vice President and Chief Financial Officer from September 2008 to March 2010, Executive Vice President and Chief Financial Officer from March 2010 to July 2011 and as a member of its board of directors from March 2010 until its acquisition by United Technologies Corporation in December 2010. From September 2005 to January 2008, Mike served as Corporate Vice President and Chief Financial Officer of Computer Sciences Corporation, an information technology and professional services company. He was also Senior Vice President and Chief Financial Officer at UNOVA, Inc., an industrial technologies company, and its predecessor company, Western Atlas Inc., from October 1996 to August 2005. Mike served as a director of MRV Communications, Inc., a publicly traded communications company, from July 2009 through January 2012, and currently serves as a director and audit committee chairman for the City of Hope, a non-profit comprehensive cancer center. His associations include memberships in the Financial Executives Institute, the American Institute of Certified Public Accountants and the Illinois CPA Society. Mike holds a B.S. in accounting from Illinois State University and an M.B.A. from the Anderson Graduate School of Management at the University of California, Los Angeles.

Bill has served as our Chief Business Development Officer since September 2010, as the Executive Chairman of our board of directors since March 2009, and as a director since January 2006. From August 1997 to September 2010, Bill served in various roles at Diversa Corporation (now known as Verenium Corporation), a biotechnology company focused on the development of biofuels, including Vice President Sales and Marketing from August 1997 to November 1999, Senior Vice President, Business Development from November 1999 to July 2002 and Executive Vice President, Business Development from July 2002 to August 2010. Prior to joining Diversa, Bill served as the Vice President of Global Sales and Marketing at International Specialty Products, Inc., a specialty chemicals company and held a variety of executive positions, both in the United States and internationally, at Betz Laboratories, Inc., a specialty chemicals company. Bill holds a B.S. in Chemistry from Widener University.

Mark has served as our Executive Vice President and Chief Technology Officer since September 2006. From November 2000 to July 2006, Mark was Senior Vice President of Research and Development at Diversa Corporation. Before that, from October 1996 to November 2000, Mark held a director position at Chiroscience Pharmaceuticals, a U.K.-based pharmaceuticals and technology company. From July 1993 to August 1996, Mark served on the faculty of the Department of Chemistry and BioChemistry at Duke University. From June 1988 to July 1993, Mark was with E. I. du Pont de Nemours and Company, or DuPont, a chemicals company. He currently serves on the editorial board of the Journal of Advanced Synthesis and Catalysis. Mark performed postdoctoral work at Massachusetts Institute of Technology and holds a Ph.D. in chemistry from Yale University and a B.A. from Rutgers University. Mark has published over 75 peer-reviewed scientific manuscripts and is an inventor on over 30 issued patents. Mark is a frequent presenter at industry conferences and received the Pew Scholar Award.

Joe has served as our Vice President, Operations and Technology Transfer since March 2010. From July 1998 to March 2010, Joe was a manager of process engineering at LyondellBasell Industries N.V., or Lyondell, a petrochemicals company. Before it was acquired by Lyondell, Joe worked at ARCO Chemical Company from June 1980 to July 1998, in research and development, plant technical and operations and process engineering. Prior to that, from June 1976 to June 1980, Joe worked in process engineering at Air Products and Chemicals, Inc., a gas and chemicals company. Joe holds an M.S. in Chemical Engineering from Lehigh University and a B.S. in Chemical Engineering from Drexel University.

Nelson has served as our Vice President of Research and Development since October 2011. From 2000 to 2011, Nelson held several roles at Verenium Corporation (formerly Diversa Corporation), including Vice President, R&D from 2008 to 2009, Sr. Vice President, R&D from 2009 to 2010 and Head of R&D starting in 2010 when Verenium’s biofuels business was acquired by BP Biofuels Corporation. From 1996 to 2000, he was Fermentation Scientist and Manager, R&D Biologics with Calbiochem-Novabiochem. Nelson holds a BA in Molecular Biology from University of California, Berkeley and a Ph.D. from University of Miami, School of Medicine. Nelson was a Postdoctoral fellow at Harvard University, Department of Cell and Development Biology and a Howard Hughes fellow at University of California, San Diego, Department of Pharmacology.

Damien has served as our Vice President, Business Development since November 2010. From February 2009 to November 2010, Damien served as Vice President of Business Development at Verdezyne, Inc., an industrial biotechnology company. From June 2007 to February 2009, Damien served in the Corporate New Ventures and Bioscience unit at Dow, and as deputy commissioner for the Queensland Government Trade Office in Los Angeles from November 2002 to May 2007. Damien holds an M.B.A. from the Anderson Graduate School of Management at the University of California, Los Angeles and a B.S. in Industrial Chemistry from the University of New South Wales.

MarySue has served as our Vice President, Intellectual Property since September 2011. From January 2007 to August 2011, she served as Senior Director, Litigation at Amylin Pharmaceuticals, Inc., a biopharmaceutical company. From September 2002 to January 2007, MarySue was Senior Counsel, IP and Litigation at Amgen Inc. and Senior Counsel, IP at 3M from February 1997 to August 2002. Before joining 3M, she was an associate at Merchant & Gould from 1994 to 1997, and a Patent Examiner at the United States Patent and Trademark Office from 1988 to 1994. MarySue holds a J.D. with honors from the George Washington University National Law Center and a B.S. in Chemistry from the University of Notre Dame.

Tina has served as our Vice President of Human Resources since November 2011. From 2008 to 2011 Tina was Vice President of Human Resources for Synthetic Genomics, Inc., a biotechnology company focused on applying genomic tools toward applications including renewable fuels and chemicals. From 2006 to 2008 Tina was HR Director for Vintage Senior Management Inc., a community of assisted living facilities. From 1996 to 2006 she held various HR positions with BD Biosciences (Becton, Dickinson and Company). Tina received her professional certification in HR from the Society for Human Resources Management and her HR Certificate in Management from Chapman College.

Steve has been consulting with Genomatica since May 2010. His consulting firm, Grey Heron, has worked with multiple cleantech firms including Aspen Aerogels, ARXX, Icynene and Xicato. Previously, Steve was Vice President, Marketing at Serious Energy from June 2006 to December 2008. Steve has held a variety of technical, marketing and management roles at companies including IBM, HP, Ingres, Central Point Software and CommerceNet. Steve has Masters and Bachelors degrees in Computer Science from MIT.